ARCHIVES

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

This article is from The Cancer Letter archive.

Vol. 30 No. 28 | July 9, 2004

Download PDF Visit The Full Archive

Related Articles

FDA Authority To Regulate Off-Label Promotion Challenged In Federal Court.

January 15, 2010

In Congress: Funds Unavailable To Give NIH Big Raise, Appropriators Say

June 5, 1998

Postponed Surgery For Low-Grade Prostate Cancer Adds No Risk

April 29, 2011

NCI Changes Deadlines For Two RFAS

July 18, 1997

In Brief: ACS Awards Three More Grants For Prevention Research; AHF Establishes Chair In Nutrition

November 14, 1980

NCI Budget: How Did NCI Spend Last Year’s Increase? Klausner Lists Activities

November 19, 1999